S.4348: Prescription Drug User Fee Amendments of 2022 Medical Device User Fee Amendments of 2022 Biosimilar User Fee Amendments of 2022 Food and Drug Administration Safety and Landmark Advancements Act of 2022 Modernization of Cosmetics Regulation Act of 2022 Verifying Accurate Leading-edge IVCT Development Act of 2022 Generic Drug User Fee Amendments of 2022 VALID Act of 2022
Sponsored by: Sen. Patty Murray
Committee On Health, Education, Labor, And Pensions. Reported By Senator Murray With An Amendment In The Nature Of A Substitute. Without Written Report. on 07/13/2022
You have voted S.4348: Prescription Drug User Fee Amendments of 2022 Medical Device User Fee Amendments of 2022 Biosimilar User Fee Amendments of 2022 Food and Drug Administration Safety and Landmark Advancements Act of 2022 Modernization of Cosmetics Regulation Act of 2022 Verifying Accurate Leading-edge IVCT Development Act of 2022 Generic Drug User Fee Amendments of 2022 VALID Act of 2022.
HB-7667: Biosimilar User Fee Amendments of 2022 Generic Drug User Fee Amendments of 2022 Prescription Drug User Fee Amendments of 2022 Medical Device User Fee Amendments of 2022
Sponsored by: Rep. Cathy McMorris Rodgers
Received In The Senate. on 06/09/2022
You have voted HB-7667: Biosimilar User Fee Amendments of 2022 Generic Drug User Fee Amendments of 2022 Prescription Drug User Fee Amendments of 2022 Medical Device User Fee Amendments of 2022.
HB-7585: Health Equity and Accountability Act of 2022 Correcting Hurtful and Alienating Names in Government Expression (CHANGE) Act Kidney Disease Research, Surveillance, Prevention and Treatment Improvement Act of 2022 Stop HIV in Prison Act Bone Marrow Failure Disease Research and Treatment Act of 2020 Viral Hepatitis and Liver Cancer Control and Prevention Act of 2022 Immigrants’ Mental Health Act of 2022 Menstrual Equity For All Act of 2021 Data to Save Moms Act Sleep and Circadian Rhythm Disorders Health Disparities Act End Tuberculosis Act Universal School Meals Program Act of 2022
Sponsored by: Rep. Raul Grijalva
Referred To The Subcommittee On Health. on 06/29/2022
You have voted HB-7585: Health Equity and Accountability Act of 2022 Correcting Hurtful and Alienating Names in Government Expression (CHANGE) Act Kidney Disease Research, Surveillance, Prevention and Treatment Improvement Act of 2022 Stop HIV in Prison Act Bone Marrow Failure Disease Research and Treatment Act of 2020 Viral Hepatitis and Liver Cancer Control and Prevention Act of 2022 Immigrants’ Mental Health Act of 2022 Menstrual Equity For All Act of 2021 Data to Save Moms Act Sleep and Circadian Rhythm Disorders Health Disparities Act End Tuberculosis Act Universal School Meals Program Act of 2022.
Protecting our Pharmaceutical Supply Chain from China Act of 2022 [HB-7121]
To require the Secretary of Health and Human Services to maintain a list of the country of origin of all drugs marketed in the United States, to ban the use of Federal funds for the purchase of drugs manufactured in the People's Republic of China, and for other purposes.
HB-7121: Protecting our Pharmaceutical Supply Chain from China Act of 2022
Sponsored by: Rep. Brian Babin
Referred To The Subcommittee On Health. on 03/18/2022
S.3799: PREVENT Pandemics Act Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act
Sponsored by: Sen. Patty Murray
Committee On Health, Education, Labor, And Pensions. Ordered To Be Reported With An Amendment In The Nature Of A Substitute Favorably. on 03/15/2022
HB-6832: To amend the Federal Food, Drug, and Cosmetic Act and the Defense Production Act of 1950 to prohibit the Federal Government from limiting State access to key therapies, such as monoclonal antibodies, and from prioritizing Federal contracts over State contracts relating to purchasing supplies to combat the COVID-19 pandemic.
Sponsored by: Rep. Andy Biggs
Referred To The Subcommittee On Health. on 02/28/2022
You have voted HB-6832: To amend the Federal Food, Drug, and Cosmetic Act and the Defense Production Act of 1950 to prohibit the Federal Government from limiting State access to key therapies, such as monoclonal antibodies, and from prioritizing Federal contracts over State contracts relating to purchasing supplies to combat the COVID-19 pandemic..
HB-6710: To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to submit to Congress a report on barriers, including regulatory inefficiencies, to domestic manufacturing of active pharmaceutical ingredients, finished drug products, and devices, and for other purposes.
Sponsored by: Rep. Alexander Mooney
Referred To The Subcommittee On Health. on 02/14/2022
You have voted HB-6710: To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to submit to Congress a report on barriers, including regulatory inefficiencies, to domestic manufacturing of active pharmaceutical ingredients, finished drug products, and devices, and for other purposes..
Free At-Home Tests for All Act [HB-6377]
To direct the Secretary of Health and Human Services to purchase and make available for free rapid tests for SARS-CoV-2, and for other purposes.
HB-6377: Free At-Home Tests for All Act
Sponsored by: Rep. Dina Titus
Referred To The Subcommittee On Health. on 01/12/2022
Registration of Certain Foreign Establishments Act [S.3449]
A bill to require foreign establishments engaged in the manufacture, preparation, propagation, compounding, or processing of a drug or device to register with the Food and Drug Administration regardless of whether the drug or device undergoes further manufacture, preparation, propagation, compounding, or processing at a separate establishment outside the United States prior to being imported into the United States.
S.3449: Registration of Certain Foreign Establishments Act
Sponsored by: Sen. Susan Collins
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 01/10/2022
S.3440: A bill to amend the Federal Food, Drug, and Cosmetic Act and the Defense Production Act of 1950 to prohibit the Federal Government from limiting State access to key therapies, such as monoclonal antibodies, and from prioritizing Federal contracts over State contracts relating to purchasing supplies to combat the COVID-19 pandemic.
Sponsored by: Sen. Ted Cruz
Read Twice And Referred To The Committee On Banking, Housing, And Urban Affairs. on 01/04/2022
You have voted S.3440: A bill to amend the Federal Food, Drug, and Cosmetic Act and the Defense Production Act of 1950 to prohibit the Federal Government from limiting State access to key therapies, such as monoclonal antibodies, and from prioritizing Federal contracts over State contracts relating to purchasing supplies to combat the COVID-19 pandemic..